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The Notch signaling pathway plays important roles in
cell-fate determination during embryonic develop-
ment and adult life. In this study, we focus on the
role of Notch signaling in governing cell-fate choices
in human embryonic stem cells (hESCs). Using ge-
netic and pharmacological approaches, we achieved
both blockade and conditional activation of Notch
signaling in several hESC lines. We report here that
activation of Notch signaling is required for undiffer-
entiated hESCs to form the progeny of all three em-
bryonic germ layers, but not trophoblast cells. In ad-
dition, transient Notch signaling pathway activation
enhanced generation of hematopoietic cells from
committed hESCs. These new insights into the roles
of Notch in hESC-fate determination may help to ef-
ficiently direct hESC differentiation into therapeuti-
cally relevant cell types.
INTRODUCTION
HumanESCs can divide indefinitely in culturewhile retaining their
pluripotency to form all the cell types derived from ectoderm, en-
doderm, mesoderm, and trophectoderm (Reubinoff et al., 2000;
Thomson et al., 1998; Xu et al., 2002). A major challenge for the
future clinical use of hESCs is to efficiently direct ESC differenti-
ation toward specific cell lineages. In addition, it is essential after
a directed differentiation procedure to separate committed pro-
genitor cells from residual pluripotent undifferentiated hESCs
that may form tumors (teratomas) after transplantation.
The extrinsic and intrinsic mechanisms governing cell-fate
choices of hESCs remain obscure. Our current knowledge ofhESC-fate determination is largely extrapolated from the studies
of mouse embryogenesis and murine ESCs (mESCs). Although
human and mouse ESCs share similar fundamental properties
such as pluripotency and unique transcriptional networking,
they differ significantly in several ways (Ginis et al., 2004;
Xu et al., 2002). For example, LIF/STAT3 signaling that is critical
for mESC self-renewal is instead dispensable for propagation of
undifferentiated hESCs (Daheron et al., 2004; Humphrey et al.,
2004). BMP4 together with LIF supports expansion of undifferen-
tiated mESCs (Qi et al., 2004; Ying et al., 2003), while BMP4
induces trophoblastic differentiation of hESCs (Xu et al., 2002).
The roles of other signaling pathways in hESCs remain to be fully
determined.
The evolutionally conserved Notch signaling pathway plays di-
verse roles in cell-fate specification in embryogenesis and adult
tissues (Artavanis-Tsakonas et al., 1999). In mammalian cells,
there are four Notch receptors (Notch1–Notch4) and numerous
transmembrane ligands such as Delta-like (i.e., DLL1 and
DLL4) and Jagged (i.e., JAG1 and JAG2). Although Notch signal-
ing in organogenesis and murine tissue-specific adult stem cells
has been well studied, its precise roles for ESCs are less un-
derstood. The Notch signaling network appears active in undif-
ferentiated mESCs (Lowell et al., 2006). After withdrawal of
self-renewal factors such as LIF and BMP4 for mESCs in culture,
active Notch signaling directed mESC differentiation toward
a neuroectodermal fate (Lowell et al., 2006). Multiple Notch re-
ceptor and ligand mRNAs are detected in multiple undifferenti-
ated hESCs, such as H1 (Brandenberger et al., 2004; Xiao
et al., 2006), H7 (Walsh and Andrews, 2003) (Enver et al.,
2005), BGN1 (Noggle et al., 2006), and line 181 (Lowell et al.,
2006). However, the exact role of Notch signaling in hESCs re-
mains elusive and controversial.
Ligand binding to a Notch receptor results in its cleavage by
a membrane-associated protease complex (g-secretase) con-
taining presenilin (Ehebauer et al., 2006; Ilagan and Kopan,Cell Stem Cell 2, 461–471, May 2008 ª2008 Elsevier Inc. 461
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(ICN) is then translocated to the nucleus, where it complexes
with the DNA-binding protein CBF1 (CSL, RBPJk, or RBPSUH),
the transactivator Mastermind-like (MAML), and other modula-
tors. The complex then binds to the cognate DNA sequence of
CBF1 and regulates the transcription of multiple effector genes,
includingmembers ofHES/HEY family such asHES1. Notch pro-
teolytic cleavage and signaling can be inhibited by g-secretase
inhibitors (GSIs), although they are not specific in blocking Notch
activation. Use of a dominant-negative form of MAML1
(DNMAML) provides a second means to block Notch/CBF1-
mediated signaling. A DNMAML-GFP fusion protein has been
shown to efficiently inhibit CBF1-mediated transcriptional acti-
vation by all four Notch receptors in vitro (Weng et al., 2003)
and in vivo (Maillard et al., 2004; Tu et al., 2005) and is also
used in this study.
Using genetic approaches and a newer GSI with reduced tox-
icity, we report here that we have achieved both blockade and
conditional activation of Notch signaling in two hESCs. We con-
firmed that the Notch/CBF1 pathway is not required or activated
in undifferentiated hESCs. However, Notch signaling activation
is required for hESCs to generate derivatives of all three embry-
onic germ layers, but not the trophoblastic lineage. Based on
these novel observations, we propose a new model for the role
of Notch signaling in governing hESC-fate choices.
RESULTS
Notch Signaling Is Elevated in Differentiated hESCs
and Inhibition of Notch Signaling Enhances the Growth
of Undifferentiated hESCs as a Population
Consistent with previously published data, we observed that
many Notch pathway genes are expressed in hESCs (Table S1
and Figure S1 available online). To directly measure endogenous
Notch/CBF1-mediated activity in hESCs, we used a luciferase
(Luc) reporter system in which Luc transcription is controlled
by the canonical CBF1 responsive element (WT-CBFRE). A re-
lated reporter with mutated CBFRE (mutCBFRE) was used as
a negative control to determine the basal level of transcription
in the same cell types studied. The CBF1 activity in differentiated
cells (obtained after teratoma formation) was 70-fold higher
than in undifferentiated cells (Figure 1A). CBF1-mediated activity
in undifferentiated and differentiated hESCs was next measured
in the presence of GSI-18 that is less toxic than the widely used
DAPT (Figure S3). GSI-18 substantially reduced the CBF1-medi-
ated activity of differentiated hESCs, while it had little effect on
mutCBFRE reporter activity.
Moreover, we analyzed the endogenous expression of major
Notch effector genes including four members of the HES/HEY
family (Figure 1B and Figure S1). As compared to differentiated
cells in teratomas (100%), the expression level of all 4 target
genes was lower in undifferentiated hESCs (Figure 1B). The ex-
pression of the DNMAML inhibitory transgene further reduced
the expression of HEY1 and HEY2, similar to the findings with
the CBF1 reporter assay. Therefore, theNotch signaling pathway
is inactive or negligibly low in undifferentiated hESCs.
To further evaluate the functional status of Notch signaling
pathway in undifferentiated hESCs, we tested if the exogenous
full-length Notch1 (N1FL) cDNA expression could turn on the462 Cell Stem Cell 2, 461–471, May 2008 ª2008 Elsevier Inc.CBF1 reporter. There was no evidence of Notch cleavage or ac-
tivation (CBF1 reporter activity) in hESCs after the transfection of
the N1FL cDNA (Figure 1C). However, in the presence of exoge-
nous Notch ligand DLL1, 6-fold increase of CBF1 activity was
observed only in hESCs transfected with the N1FL cDNA. Inter-
estingly, functional JAG1 treatment (Figure S2C) did not lead to
active Notch1 cleavage. Our data confirm that Notch signaling
pathway is inactive in undifferentiated hESCs, but can be acti-
vated if both exogenous Notch1 receptor and ligand (DLL1) are
provided.
Next we examined the kinetics of Notch signaling activation in
differentiating hESCs (Figures 1D–1F). A standard method to dif-
ferentiate ESCs is to form embryoid bodies (EBs) in the presence
of serum. First, we transfected a CBFRE-GFP reporter plasmid
(Duncan et al., 2005; Mizutani et al., 2007) into undifferentiated
hESCs, which were subsequently induced to differentiate by
EB formation. Positive GFP expression started to appear one
day after EB formation and further intensified during the culture
(Figure 1D). In contrast, no GFP expression was found if the
transfected hESCs were cultured in self-renewal maintaining
medium. By western blot, we observed the cleaved Notch1 pro-
tein (cN1) peaked on day 2 and diminished on day 3 after EB for-
mation (Figure 1E). In addition, DLL1 protein expression was also
elevated 48 hr after differentiation (Figure 1F). These data pro-
vide strong evidence that Notch signaling is activated in the initial
stage of hESC differentiation.
Notch activation at the single-cell level 48 hr after EB formation
was also examined by using the anti-cN1 antibody (Figures 1G
and 1H). We observed that cN1+ cells were largely lacking
Oct4 expression (Figure 1G), whereas many coexpress a line-
age-commitment marker Nestin (Figure 1H). The data indicate
that Notch activation in hESCs is associated with exiting from
the undifferentiated state and differentiation commencement.
We next examined directly the effects of Notch signaling
blockade on the growth of undifferentiated hESCs (Figures 1I
and 1J). As compared to the GFP control, GSI-18-treated or
DNMAML-transduced H9 hESCs generated greater numbers
of total cells after 5 days of culture and a higher frequency of col-
ony-forming (self-renewing) undifferentiated hESCs, resulting in
a total of 2.5-fold more undifferentiated colonies (Figure 1I). Sim-
ilar results were obtained with the H1 hESC line expressing
DNMAML, although the GFP-transduced or parental H1 hES
controls also grew quite robust. We further characterized these
DNMAML+ cells by examining the expression of undifferentiated
ES markers Oct4 and Tra-1-60 (Figure 1J). The percentage of
Oct4+Tra-1-60+ cells with DNMAML transduction was compara-
ble to the control hESCs. Moreover, both DNMAML+ H1 and H9
hESCs can be cultured for 30–40 passages and remain pheno-
typically normal (data not shown). Therefore, the observed low-
level Notch/CBF1 activity in undifferentiated hESC populations
appears inessential for their self-renewal and is likely derived
from aminor fraction of spontaneously differentiating or differen-
tiated progeny in the standard hESC culture.
Active Notch Signaling Initiates the Differentiation
of hESCs
Conversely, we examined the consequence of induced Notch
signaling activation in hESCs, either by exposure to the Notch
ligand DLL1 or by enforced expression of ICN1 or HES1
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and Differentiating hESCs
(A) Undifferentiated ESCs (H1) were cocultured
with MEFs in the presence or absence of GSI-18
(10 mM) for 3 days. Dissociated teratoma-derived
cells were cultured in the same manner. The cells
were then transfected with CBFRE-Luc construct
together with b-gal expression plasmid overnight
and subjected for Luc assays.
(B) Gene expression of representative Notch
downstream target in H9 hESCs transduced with
either DNMAML or the parental control lentivector.
The relative level of each gene in the teratoma was
defined as 100%. The asterisk indicates a very low
level of HES5 expression in GFP and DNMAML.
(C) H1 hESCs were overlaid on 3T3 cells express-
ing DLL1 or JAG1 for 1 day before transfection.
CBFRE-Luc with full-length Notch1 expression
vector (pBOS-N1FL) or parental vector was co-
transfected into cells.
(D) CBFRE-GFP was electroporated into H1 cells.
Except for an aliquot of cells continuously cultured
under the ES culture condition, remaining trans-
fected cells were induced to form EB in the pres-
ence of 20% FBS.
(E and F) EBs derived from H9 hESCs were col-
lected daily for protein isolation. The expression
of cleavage Notch1 (cN1) (E) and DLL1 protein
(F) was detected by western blot. The proteins of
mouse E14 germinal eminence were served as
positive control for cleavage Notch1 (E).
(G and H) cN1(G and H), Oct4 (G), and Nestin (H)
expression at the single cell level (H1 hESCs)
2 days after EB formation. Similar results were
obtained in H9 EBCs. Scale bar, 100 mm.
(I) Self-renewal capacity in hESCs in which endog-
enous Notch activity was blocked by either
DNMAML or GSI-18. hESCs were plated in 24-
well Matrigel-coated plate at a density of 3 3 104
per well and cultured in the presence or absence
of GSI-18 (20 mM) for one passage of 5 days. Cells
were counted at the end of each passage. The fre-
quency of colony-forming undifferentiated hESCs
(AP+) per 1000 harvested cells were also assayed
after plating them on MEFs in 96-well plates for
5 to 6 days. Relative levels of colony-forming
(CF) abilities were calculated by multiplying fre-
quency of AP+ colonies by the total cell number before colony assay. The level of CF ability of either DNMAML+ or GSI-treated cells was expressed relative
to the mean of the control ESCs, which was arbitrarily defined as 1. These experiments were repeated 3–6 times, and the pooled results are plotted (nR 15).
(J) The percentages of Oct4+Tra-1-60+ control or DNMAML+ H1 cells were determined by FACS analysis. A representative data set from three independent
experiments was shown.transgene (Figure 2). First, hESCs were cocultured with 3T3-
DLL1 or control 3T3 cells in undifferentiated hES culture medium
(Figure 2A). hESCs cultured on 3T3-DLL1 cells for 4 days gener-
ated significantly fewer alkaline phosphatase positive (AP+)
undifferentiated colonies (Figure 2A; Figure S4). We further con-
firmed this observation by culturing hESCs with purified DLL1
(Varnum-Finney et al., 2000). The purified DLL1 as an IgG fusion
protein (DLL1ext-IgG) or IgG control was immobilized in Matrigel,
which provides a feeder-free substrate. Eight days after treat-
ment, comparable numbers of cells were harvested (Figure S5A).
About 13% of DLL1-treated hESCs (GFP+) lost Oct4 expression,
whereas only 2% of cells were Oct4 negative in the control
IgG group (Figure 2B). The number of undifferentiated hES
colonies was reduced by >10-fold after the DLL1 treatment ina more stringent AP+ colony-forming assay (Figure 2C; Fig-
ure S4B).
We also attempted to obtain stably transduced hESCs using
lentiviral vectors coexpressing GFP and either ICN1 or HES1. Al-
though transduced (GFP+) ESCs were observed initially, ICN1-
transduced cells (data not shown) and HES1-transduced cells
disappeared after a few passages (Figure S6). In contrast,
100% of transduced cells in the control (GFP or ID1) groups
remained Oct4+ (Figure S6).
To better assess the effects of ICN1 or HES1 overexpression
in hESCs, we utilized lentiviral vectors expressing a form of
ICN1 as an estrogen receptor (ER) fusion protein (ICN1-ER;
Figures S2A and S2B) and HES1-ER (Yu et al., 2006). In the
absence of 4-hydroxytamoxifen (4HT) induction, ICN1-ER- orCell Stem Cell 2, 461–471, May 2008 ª2008 Elsevier Inc. 463
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lar self-renewal ability comparable to the control GFP vector
(Figures 2D–2G). Upon induction with 4HT, however, ICN1-ER+
Figure 2. Active Notch Signaling Initiates Lineage Commitment of
hESCs
(A) H9 ESCs were overlaid on 3T3 cells in the presence of MEF CM for 4 days.
On Day 4, 1/15 of the trypsinized cells were replated on MEFs in 96-well plate
for quantitative colony formation (n = 8 per group). A representative data set
from three independent experiments is shown.
(B and C) 105 of GFP+ hESCs (H1) were plated in the 6-well plates precoated
with 10 mg/ml of DLL1ext-IgG or control human IgG proteins. On Day 8, the per-
centage of Oct4+ cells was measured by FACS (B). The harvested cells were
further plated onto MEFs at a density of 23 104 per well for colony forming as-
say (C) (n = 8). Three independent experiments were performed.
(D and E) H9 cells stably transduced with parental or ICNER lentivector were
cultured on Matrigel in the absence or presence of 4HT (200 nM) for 6 days.
2000 of trypsinized ESCs were replated for colony forming assay (D). In an in-
dependent experiment, 8 day treated cells were stained for Oct4 antibody (E).
(F and G) Control or HES1-ER+ hESCs (H1) were cultured on Matrigel in the
presence or absence of 4HT (200 nM) for two passages. Then, dissociated
cells were plated in triplicates at a density of 104 in 12-well of Matrigel-coated
plates. After 4 days of culture, colonies were stained for the AP (F) and counted
(G). Three independent experiments were performed.464 Cell Stem Cell 2, 461–471, May 2008 ª2008 Elsevier Inc.ESCs lost 92% of their colony-forming ability after one passage
(Figure 2D). The Oct4 expression was also diminished in the
majority of the ICN1-ER+ cells (Figure 2E). Similarly, activation
of HES1 by 4HT in hESs coexpressing HES1-ER and GFP trans-
genes led to a significant phenotypic change (Figure 2F). Eventu-
ally, the majority of cells lost their colony-forming ability after
10 days of 4HT induction (Figure 2G).
We monitored closely the numbers of viable and apoptotic
cells after Notch activation. Similar numbers of cells were ob-
served in both IgG and DLL1ext-IgG treated hESCs (Figure S5A).
The total number of viable cells or the percent viable cells
(Annexin/7AAD) in the ICN1-ER+ hES group was similar to
those of the control groups (Figures S5B and S5C). Thus, the re-
duction of undifferentiated hESCs after Notch activation primar-
ily results from cell differentiation rather than decreased prolifer-
ation or increased apoptosis.
A Pulse of Notch Signaling Is Required for hESCs to
Form the Progeny of All Three Embryonic Germ Layers
Next, we examined the role of Notch signaling in the differentia-
tion commitment of hESCs through EB formation. In the control
hESC group (GFP+), the size of aggregates increased with time,
and more structured (cystic) EBs were visible after 3 days
(Figure 3A). However, hESCs in which Notch signaling was
blocked by DNMAML formed cystic EBs poorly, despite the
fact that they appeared normal in their undifferentiated hESC
state. To exclude the possibility that the observed effects might
be due to increased apoptosis in Notch inhibited cells, we exam-
ined the cells for signs of apoptosis before and after the switch of
culture conditions. No differences were observed in DNMAML+
cells, as compared to controls (Figure 3B).
To quantify the spectrum and degree of differentiation, EBs
were collected at different stages and analyzed by RT-PCR for
the expression of representative markers of various embryonic
cell lineages. After 5 days, the levels of PAX6 (ectoderm marker),
AFP (endoderm marker), and CD34 and SCL/TAL-1 (mesoderm
markers) were sharply elevated in the control hESCs from
undetectable at day 0 (data not shown) to levels comparable
(or higher for AFP) to those of teratoma cells (Figure 3C). How-
ever, the expression of these markers was significantly lower in
the DNMAML-transduced group, suggesting that differentiation
into the progeny of all three embryonic germ layers is blocked.
We also analyzed the expression ofNANOG andOCT4 (undiffer-
entiated ESC markers) in these cells. The DNMAML+ cells ex-
pressed more than 20-fold higher levels of NANOG or OCT4,
as compared to that of the control group, further indicating
that blocked Notch activity inhibited ESC differentiation. Similar
results were found in both H9 and H1 cells treated with GSIs
(Figures 3F and 4A).
Inefficient EB formation observed with DNMAML+ hESCs may
result from poor cell-cell contact, which in turn might affect dif-
ferentiation within EBs. Thus, we used a method to generate
EBs that forces cell-cell contact in 96-well microtiter plates
(Ng et al., 2005). In marked contrast to the control group, few
of DNMAML+ EBs became cystic after 12 days of culture
(Figure 3D). This reduced cystic EB formation was also seen in
the wild-type hESCs after GSI (GSI-18 or GSI-2) treatment. In
the presence of DMSO vehicle alone, 70% of EBs transduced
with either control or HES1-ER lentivector was cystic (Figure 3E).
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tion (<10% of total EBs were cystic) in the control group. The
inhibition of cystic EB formation by GSI was largely rescued by
the HES1 gene expression: 50% of the HES1-ER+ EBs re-
mained cystic at the end of a 12 day culture in the presence of
4HT induction.
Next, we analyzed the expression of lineage markers of the
three embryonic germ layers in theday12EBs formed in thepres-
ence or absence of GSI, from either control or the HES1-ER-
transduced hESCs (Figure 3F). As expected, GSI-treated cells
transducedwith the control lentivector showed severely reduced
expression of all the lineage markers used (AFP, PAX6, CD34,
and TAL-1). In contrast, HES1-ER activation by 4HT resulted in
the partial restoration of expression of the differentiation markers
in GSI-treated cells, suggesting that the observed GSI effect
in this system is Notch signaling specific. Collectively, our
data demonstrate that Notch signaling is required for lineage
commitment to form cell derivatives of the three embryonic
germ layers.
A pulse of Notch signaling observed within 48 hr of EB differ-
entiation (Figures 1D–1F) may be essential for lineage commit-
ment of hESCs. To test this hypothesis, GSI-18 (or DMSO
Figure 3. Notch Signaling Is Required for the Differentia-
tion of hESCs into the Progeny of the Three Germ Layers
In Vitro
(A–C) hESCs (H9) were cultured in the presence of 20% FBS to in-
duce EB formation. (A) EBs of day 3 were shown. (B) The percent
of viable cells was determined. Two independent experiments
were performed with duplicates per group in each experiment.
(C) Gene expression in day 5 H9 EBCs. The expression level of
each gene in teratoma was arbitrarily set as 1.
(D–F) 1000 H1 cells were forced to aggregate after centrifugation
in 96-well plate. 1 to 2 EBs were formed in each well after 12 day
culture (D). (E) ESCs were differentiated in the presence or ab-
sence of 10 mM of GSI-2. 200 nM of 4HT were added into all cul-
tures to induce the functional HES1 expression. Cystic and total
day 12 EBs were documented. Three independent experiments
were grouped to present here. (F) Enforced expression of HES1
partially restored the normal EB (day 12) differentiation blocked
by GSI. The expression of each gene in DMSO treated control
EB was normalized to 1. (*Ct = 0 after 40 cycles).
vehicle) was added into the culture at either the be-
ginning of EB formation or 2 days later. In contrast
to the significant changes observed if GSI treatment
started at day 0 (Figure 4A), starting GSI treatment
at day 2 had little effects on EB maturation or gene
expression patterns in EB-derived cells at day 6
(Figure 4B). The data confirmed that a pulse of Notch
signaling within first 48 hr of EB formation is required
for hESC to differentiate and commit to the three em-
bryonic lineages.
Notch Signaling Blockade Preserves
Undifferentiated hESCs after Induced
Differentiation In Vitro
High levels of NANOG and OCT4 mRNA expression
were detected after differentiation induction in hESCs
with reduced Notch activity (Figures 3C and 4A), indicating that
some ESCs remained undifferentiated within EBs. We stained
day 6 EBs to detect the level of nuclear Oct4 protein (Figure 4C).
Significant numbers of Oct4+ cells remained in the DNMAML
group. In contrast, only a few scattered Oct4+ cells were ob-
served in control ESC-derived EBs.
Next, we assessed the content of remaining undifferentiated
hESCs in the DNMAML group during a prolonged differentiation
culture. Day 12 EBs were dissociated into single cells and plated
on feeder cells in culture conditions designed to maintain undif-
ferentiated hESCs. The number of AP+ colonies derived from the
DNMAML+ group was 4-fold higher than that of the control EBCs
(Figure 4D), indicating that reduced Notch activity prevented the
undifferentiated hESCs from entering differentiation. To induce
further in vitro differentiation, day 12 EBs were transferred onto
mouse OP9 cells and cultured for an additional 7 days. Then,
all cells were harvested for immunostaining for Tra-1-60 (an un-
differentiated marker) and Tra-1-85, a marker unique for human
cells (Figure 4E). After a two-step, 19 day differentiation, only
11%–13% of untransduced or parental GFP-transduced cells
remained Tra-1-60+. In contrast, 54% of DNMAML+ cells still
expressed Tra-1-60.Cell Stem Cell 2, 461–471, May 2008 ª2008 Elsevier Inc. 465
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Differentiation after Mesoderm Commitment
Next, we examined whether Notch activation by HES1 over-
expression enhanced hematopoietic differentiation after
mesoderm commitment (Figure 5). HES1-ER+ EBs aggregated
in the presence of 4HT for 12 days generated more hemato-
poietic colonies than control EBs (Figure 5A). When EB-derived
cells were allowed to further differentiate on OP9 stromal cells
for 7 days, 39% of the cells in the HES1-ER group were
CD34+CD45+. In contrast, only 13% of the cells were CD34+CD45+
in the control (GFP only) group (Figures 5B and 5C). Notably,
4HT was added only during the first stage of differentiation
(EB formation) to activate the HES1-ER transgene, but not in
the two subsequent hematopoietic assays. If exposure to 4HT
was continued during the hematopoietic assays, however, cell
proliferation was reduced (data not shown). This is consistent
with our previous observation that continued HES1 overexpres-
sion inhibited postnatal mouse and human hematopoietic
Figure 4. A Pulse of Notch Signaling Is Essential for
Lineage Commitment of hESCs
(A and B) H9 ESCs were induced to differentiate into EBs in the
presence of 20% FBS for 6 days. Continuous treatment of GSI-
18 (20 mM) or DMSO was started on Day 0 (A) or Day 2 (B). The
mRNA level of the day 6 EBCswasmeasured by qRT-PCRand ex-
pressed relative to the mean of the teratoma (which was normal-
ized to 1). * indicates Ct = 0 (undetected) after 40 cycles.
(C–E) Blocking Notch signaling preserves uncommitted hESCs
during differentiation in vitro. (C) Day 6 whole EBs (H9) were
stained for Oct4 antibody. (D) 1000 of dissociated day 12 EBCs
were cultured on MEFs in 96-well plate for 7 days. Colonies
were further stained for AP. The number of colonies derived
from control EBCs were normalized to 1. (E) Day 12 EBs (H1)
were cultured on plain OP9 cells for 6 days. Cell mixtures were
then isolated and costained with anti-Tra-1-60 (ESC marker) and
Tra-1-85 (human cell marker) antibodies.
progenitor cell proliferation (Yu et al., 2006). Our re-
sults demonstrated that controlled activation of Notch
signaling can be used to direct differentiation of
hESCs to a specific lineage under appropriate culture
conditions.
Blocking Notch Signaling Favors Trophoblastic
Lineage Commitment upon Differentiation
Induction
In addition to cells derived from the three embryonic
germ layers, hESCs can differentiate into trophoblasts
by either EB formation (Gerami-Naini et al., 2004) or
BMP4 induction (Xuet al., 2002). Toexamine thepoten-
tial role of Notch signaling in trophoblastic differentia-
tion, we first analyzed the expression of trophectoderm
markers (i.e., CDX2, chorionic gonadotropin A and B
[CGA, CGB]) within EBs (Figures 6A–6C). Levels of
mRNA of these genes were significantly elevated in
differentiating DNMAML+ EBCs (H1) compared to the
control groups (Figures 6A–6C). Similar results were
observed with H9 hESCs, when whole EBs were
stained for trophoblastic markers such as TROMA-I
(Figure 6D).More TROMA-I+ cells were observed in the peripheral
zones of DNMAML+ EBs than that of control EBs (Figure 6D). We
also measured by FACS what proportion of the cells in EBs (day
12) expressed trophoblasticmarkers. TROMA-I orb-hCGwasex-
pressed in 5% to 6%of DNMAML+ EBCs. In contrast, <1%of the
control EBCs expressed trophoblastic markers (Figure 6E).
The effect of Notch blockade on BMP4-induced trophoblastic
differentiation was also examined in several transduced hESC
lines (Figures 6F–6H). Cells were plated at the same density
and induced by BMP4 for 10 days. Supernatants were then col-
lected for measuring b-hCG hormone production by ELISA. Rel-
ative to cells transduced with the control lentivector, the HES1+
cells produced only 20% of the hCG protein (Figure 6G). In con-
trast, hESCs transduced with a HES1 DNA-binding mutant
(DBHES1) showed normal hCG production. Reduction in hCG
production was also observed in ICN1+ ESCs (Figure 6F). Block-
ing Notch activity using a GSI resulted in a 2-fold increase in hCG
production in control cells, but not in ICN1+ cells. We also466 Cell Stem Cell 2, 461–471, May 2008 ª2008 Elsevier Inc.
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produced5-fold higher levels of hCG, as compared to the level
measured in control groups (Figure 6H). Together, these results
demonstrate that trophoblastic differentiation is inhibited by the
activated Notch signaling.
Blocking Notch Signaling Affects hESC Fate during
In Vivo Differentiation
We next examined cell-fate choices of hESCs in vivo during ter-
atoma formation from control and DNMAML-transduced hESCs.
GFP (control) and DNMAML-transduced ESCs (both H1 and H9)
were injected into mice. After 3 to 4 months, palpable tumors
were excised. Both control and DNMAML groups formed tumors
at similar rates, and no significant difference in size or weight was
observed (data not shown). We examined whether DNMAML
remained functional in teratoma cells by examining CBFRE-
Figure 5. Transient Activation of Notch/HES1 Signaling Promotes
Hematopoietic Differentiation
(A) 3000 of control or HES1-ER+ ESCs (H1) were forced to aggregate in 96-well
plates in the presence of BMP4 (10 ng/ml), VEGF (5 ng/ml), Flt-3 ligand
(5 ng/ml), SCF (20 ng/ml), IL-6 (5 ng/ml), and 200 nM of 4HT. 1.7 3 104 disso-
ciated EB12 cells were plated in methylcellulose supplemented with IL-3,
GM-CSF, and Epo for hematopoietic colony assay.
(B andC)Whole EBs (day 12) were transferred onto OP9 cells in the absence of
4HT. Seven days later, cells were harvested for FACS analysis (C). Human cells
were gated based on the positive GFP and Tra-1-85 staining shown in (B).Luc activity after overexpression of ICN1. Interestingly, four out
of seven teratomas in the DNMAML-transduced group showed
a low level of CBF1 activity even after ICN1 activation, indicating
an active DNMAML inhibition (DN-active) as expected. However,
the remaining three teratomas in the DNMAML-transduced
group showed a high CBF1 activity, comparable to control
Figure 6. Blockade of Notch Signaling Favors Trophoblastic Differ-
entiation of hESCs
(A–C) Gene expression of trophectoderm markers in day 7 EBs (H1). Control
EBs (n = 3); DNMAML+ EBs (n = 4).
(D) TROMA-I staining in day 14 EBs (H9).
(E) Day 12 EBs (H9) were dissociated into single cells and stained with either
TROMA-1 or b-hCG antibody for FACS analysis.
(F–H) 105 of hESCs were plated in the presence of BMP4 (50 ng/ml) for 10
days. The supernatants were collected for hCG measurement. The cell lines
examined were cells transduced with parental, ICN1-ER (F), HES1-ER,
DBHES1-ER (G), and DNMAML lentivector (H). (F) 200 nM of 4HT was added
during the 10 day culture to induce functional ER fusion protein expression in
H1 cells. Cells were also treated with either DMSO (empty bar) or 10 mM of
GSI-2 (filled bar). Three independent experiments were performed and data
were grouped here.Cell Stem Cell 2, 461–471, May 2008 ª2008 Elsevier Inc. 467
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Notch Signaling Regulates Human ESC-Fate Choices(GFP) teratomas (as shown in Figure 1A). This DNMAML-trans-
duced subgroup is distinct from the four DN-active teratomas.
It is likely that the DNMAML-mediated inhibition was silenced af-
ter several months in vivo in these three teratomas (designated
as DN-si). We observed the expression levels of representative
lineage/differentiation marker genes, GATA4 (endoderm
marker), PAX6 (ectoderm marker), and T (Brachyury, mesoderm
marker), were reduced in harvested DN-active cells. In contrast,
the expression of these representative lineage markers in the
DN-si teratoma cells was more similar to the control (GFP) tera-
toma cells (Figure 7A). In addition, the expression of trophoblas-
tic markers was increased by >3-fold in DN-active cells com-
pared to the control and DN-si groups. NANOG gene
expression was 3.5-fold higher in the DN-active cells than those
in the control or DN-si group, indicating that active DNMAML
inhibition reduced the differentiation of hESCs in vivo.
Freshly isolated teratoma cells were also analyzed by FACS for
the presence of cells that retained undifferentiated hESC pheno-
type (Tra-1-60+) (Figure 7B). On average, 3.5% of the teratoma
cells in the DNMAML group (n = 6) expressed Tra-1-60, whereas
only about 0.5% of teratoma cells in the control group (n = 5) re-
mained Tra-1-60+. To directly evaluate the content of remaining
undifferentiated hESCs within teratomas, 106 of dissociated ter-
atoma cells from the DN-active group were plated onto feeder
cells under hESC culture condition. Seven to nine days later, un-
differentiated hES colonies appeared, which were stained posi-
tive for AP activity (Figure 7C). No AP+ colonies were generated
from the control tumors. Furthermore, secondary AP+ colonies
were formed after the primary culture was replated on MEFs
(Figure 7D). Tertiary hES-like colonies were also formed and
Oct4+ and Tra-1-60+ (Figure 7E). In summary, an enhanced level
of undifferentiated hESCswas observed in the teratoma in which
DNMAML-mediated blockade remained active months after
differentiation induction in vivo.
DISCUSSION
Using both genetic and pharmacological approaches, we exam-
ined the role of Notch signaling in both self-renewal and differen-
tiation of hESCs by a series of gain-of-function and loss-of-func-
tion studies. First, we confirmed that Notch signaling is inactive
in undifferentiated hESCs, which is in agreement with a recent
report (Noggle et al., 2006). Neither Notch cleavage nor CBF1
activity was detected (Figures 1C–1F). In contrast, Notch signal-
ing was activated in differentiating hESCs. We observed that
a transient wave of Notch signaling activation appeared after in-
duced EB formation and peaked around 48 hr after differentia-
tion (Figures 1D–1F). Notch activation in hESCs correlates the
Oct4 expression reduction (Figures 1G, 2B, and 2E), the exit
from the undifferentiated state and differentiation initiation (Fig-
ures 1G and 1H). We demonstrated that this wave of Notch sig-
naling activation is essential for hESC lineage commitment to the
progeny of the three embryonic germ layers (Figures 3A and 4A).
However, the cells were able to differentiate to a level compara-
ble with control cells if Notch signaling blockade was delayed for
48 hr (Figure 4B). Whether such a wave occurs during human
embryonic development in vivo is of great interest to investigate.
Our data demonstrated that the Notch signaling pathway is
inactive in undifferentiated hESCs, although a minor fraction of
spontaneously differentiating or differentiated progeny cells
displayed Notch/CBF1 activity. Short-term DLL1 stimulation
(2 days) was not sufficient to trigger the endogenous Notch
cleavage monitored by the CBF1 activity in undifferentiated
hESCs, unless the additional exogenous N1FL cDNA was pro-
vided as well (Figure 1C). This implies that the levels of Notch re-
ceptors and ligands in undifferentiated hESCs are below the
threshold of activation. It remains to be determined how Notch
signaling is activated upon differentiation induction in hESCs,
which are capable of responding to the exposure of an
Figure 7. Blocking Notch Signaling Alters hESC
Differentiation In Vivo
Control or DNMAML-transduced hESCs were injected intra-
muscularly into the SCID/Beige mice. Palpable teratoma
was dissected into pieces for various assays. The induction
of CBFRE-Luc activity by ICN1 was examined in dissociated
DNMAML+ tumor cells. The DNMAML tumor cells that showed
restored ICN1-induced CBF1 activity was designated as
silenced DNMAML cells (DN-si).
(A) qRT-PCR analysis of gene expression in teratoma cells
(H9). The gene expression level of control teratoma cells was
normalized as 1. (Control = 3; DN+ = 4; DN-si = 3).
(B) Dissociated teratoma cells (H1) were immunostained for
Tra-1-60 and Tra-1-85 antibodies and analyzed by FACS.
Human cells were gated based on positive Tra-1-85 staining.
(Control = 5; DNMAML = 6).
(C) 106 of teratoma cells (H1) were replated onto MEFs in
6-well plateandcultured inESmedia for 7–9days. Thesurvived
cells were then stained for AP. (Control = 8, DNMAML = 9).
(D) In secondary colony assay, teratoma-derived primary colo-
nies were collected and replated (ratio of 1:1) onto new MEF
cells. The cells were cultured for 7 more days and stained
with AP. Three control and three DNMAML teratoma samples
were used in this assay. (Asterisks indicate no colonies
formed).
(E)Characterization of a tertiary colonyderived fromDNMAML-
transduced teratoma cells.468 Cell Stem Cell 2, 461–471, May 2008 ª2008 Elsevier Inc.
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possibilities we can postulate. First, the pulse of Notch activation
(Figure 1E) may result from increased cell-cell contact during EB
or teratoma formation with increased Notch ligand density or li-
gand-receptor interactions. Second, the differentiation induction
may increase expression levels or activities of Notch receptors
and/or ligands. In fact, our data showed that DLL1 expression
was significantly increased within the first 48 hr of EB differenti-
ation relative to undifferentiated hESCs (Figure 1F). We also ob-
served the increased Notch1 receptor gene expression by about
1.5-fold in differentiated hESCs by qRT-PCR (Figure S1). Despite
of the uncertainty of which and how many mechanisms are
involved, our current data nonetheless suggest that Notch
signaling plays an active role in hESC differentiation. Better
understanding the regulation of Notch regulators in a cell
context-specific manner may help us to better understand initial
key events during the hESC lineage commitment.
In addition to the understanding of a critical role of Notch sig-
naling pathway in the initiation of hESC lineage commitment, our
study also suggests that manipulation of Notch signaling at a
later stage of differentiation is likely to be useful in specification
of hESC into tissue-specific progenitors. The promotion to the
ectodermal-neural lineage by Notch activation was shown in
mESCs and one hESC line (Lowell et al., 2006). The authors
also showed that Notch activation in mESCs after the stage
equivalent to the epiblast formation simultaneously suppressed
nonectodermal commitment while promoting the ectodermal-
neural lineage (Lowell et al., 2006). Here, we observed that Notch
signaling promotes differentiation of hESCs to generate the
progeny of not only the ectoderm lineage, but also mesoderm
and endoderm lineages. For example, we found that transiently
overexpressed HES1 enhanced production of hematopoietic
cells derived from mesoderm precursors (Figure 5).
Our current studies benefited from our improved ability to
transduce hESCs efficiently and stably with lentiviral vectors.
However, we noticed that, in every case, transgene expression
driven by a housekeeping gene promoter was gradually silenced
in hESCs in the absence of continuous selection (Zhou et al.,
2007). The silencing of DNMAML-GFP transgene expression
was also observed in DNMAML-GFP-transduced hESCs after
initial selection of GFP+ hESCs. Three teratomas derived from
the DNMAML-transduced cells found that the inhibitory effect
of DNMAML on Notch signaling was lost probably due to gene
silencing. Interestingly, the expression of all the three embryonic
germ layer markers in these three teratomas was comparable
with the control cells (Figure 7). In contrast, the markers were ex-
pressed at a reduced level in DNMAML-active teratomas. This
indicates that hESCs in which endogenous Notch signaling
was initially blocked were able to retain differentiation ability
once Notch signaling activation was restored.
Our data support an emerging notion that a GSI with low cyto-
toxicity can be used to enhance the maintenance of undifferen-
tiated hESCs by preventing spontaneous differentiation occur-
ring commonly in current culture systems (Figures 1I and 1J). It
was postulated previously that Notch signaling is associated
with or important to self-renewal of hESCs (Androutsellis-Theo-
tokis et al., 2006; Fox et al., 2008). The latter postulation was
based largely on mRNA expression data and the use of GSI
such as DAPT (Androutsellis-Theotokis et al., 2006) andL685458 (Fox et al., 2008) that reduced numbers of total and col-
ony-forming hESCs. The reduction of hESCgrowth byDAPTwas
also observed by us (Figure S3) and others (Noggle et al., 2006),
possibily resulting from nonspecific toxicity of the chemical. In
fact, analysis of survived hESCs after DAPT treatment revealed
that they are more homogenous as undifferentiated hESCs
(Noggle et al., 2006). A newer GSI we used, GSI-18, showed
no toxicity in contrast to DAPT (Figure S3) and actually enhanced
the growth of undifferentiated hESCs by preventing spontane-
ous differentiation (Figure 1I). Corroboratively, there is no con-
vincing evidence that the Notch pathway is involved in the self-
renewal of mESCs, either. It is well known that embryos deficient
in the genes encoding various Notch pathway components can
develop to midgestation stages but die around embryonic day
8–11 (Yoon and Gaiano, 2005). Furthermore, Notch1- or CBF1-
deficient mESCs can be established and maintained with undif-
ferentiated phenotypes, although they show abnormalities after
differentiation induction (Nemir et al., 2006).
We also examined the Notch effect on trophoblastic differen-
tiation of hESCs. Surprisingly we found that blockade of Notch
signaling promoted the expression of trophoblasticmarkers (Fig-
ures 6A and 7B) and increased the proportion of cells expressing
trophoblastic markers during in vitro differentiation (Figures 6D
and 6E). Overexpression of ICN1 or HES1 resulted in inhibition
of hCG production (Figures 6F–6H). Taken together, our data
demonstrate that Notch activation in hESCs promotes their com-
mitment to form the progeny of all three embryonic germ layers
but inhibits trophoblast differentiation, an alternative cell-fate
choice at this stage. The observed fate choices between twoma-
jor differentiated lineages of hESCs resembles the well-known
phenomenon of ‘‘lateral inhibition,’’ in which Notch activation
helps to generate more than one type of committed progeny
within an initially uniform stem/progenitor cell population
(Bray, 2006).Wepropose a simplemodel to illustrate the essence
of our findings on the role of Notch signaling on hESC-fate deter-
mination (Figure S7). This model is consistent with a common
theme of Notch signaling in stem cell regulation, emerged from
various stem cell systems (Ohlstein and Spradling, 2007).
Although cell context dependent, Notch signaling appears pri-
marily involved in the specification of cell fate instead of acting
directly on stem cell survival, proliferation, or maintenance. A de-
tailed analysis of the Notch pathway and its interactions with
other regulators will help us to better understand the mechanism
of cell-fate determination of hESCs.
We observed differences between hESCs and mESCs in
response to Notch activation, as to other cues such as BMP4.
Mouse ESCs can tolerate overexpression of ICN1 (6-fold)
without altering their undifferentiated phenotype under culture
conditions designed to promote self-renewal and maintain pluri-
potency (Lowell et al., 2006). In contrast, hESCs lost their self-re-
newal capacity and differentiated by either sufficient exposure to
exogenous DLL1 ligands or overexpression (5-fold) of ICN1 or
HES1 (Figure 2). Other differences between hESCs and mESCs
were revealed by induced differentiation. In the absence of two
key self-renewal factors for mESCs, LIF and BMP4, active Notch
signaling favors mESC differentiation into a neuroectodermal
fate (Lowell et al., 2006). Interestingly, shutting down of Notch
signaling is required for cardiogenesis from mES-derived EBs
(Nemir et al., 2006; Schroeder et al., 2006). For hESCs, weCell Stem Cell 2, 461–471, May 2008 ª2008 Elsevier Inc. 469
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tion induction and is essential for hESC commitment to form the
progeny of all three embryonic germ layers. We also found that
blockade of the Notch pathway increased the proportion of tro-
phoblast cells as well as undifferentiated hESCs. Currently, we
do not know whether the promotion of trophoblastic differentia-
tion by Notch pathway blockade is a direct or indirect effect.
In summary, this is the first comprehensive study to define the
role of Notch signaling in the decision of hESCs to self-renew or
differentiate and in cell-fate choices between embryonic and
trophoblastic cell lineages upon differentiation induction. For
the initial cell-fate determination of undifferentiated hESCs, ac-
tive Notch signaling was only required for the commitment to
form cells of all the three embryonic germ layers, but not for
self-renewal or trophoblastic differentiation. Our data shed light
on one mechanism governing hESC-fate determination and
open the possibility of manipulating Notch signaling to more
efficiently promote directed differentiation of hESCs or other
forms of pluripotent stem cells into therapeutically relevant
cell types.
EXPERIMENTAL PROCEDURES
Human ESC Culture
H1 and H9 hESC lines were obtained from WiCell Research Institute. See the
Supplemental Data for detailed culture conditions.
Teratoma Formation
hESCs were scraped from the plate and resuspended in 250 ml of HBSS and
injected into the leg muscle of 4-week-old SCID/Beige mouse. Palpable tera-
toma (after 3 to 4 months) was excised for further analysis.
Transduction of hESCs
Concentrated lentiviruses were added into the 80% confluent cells in the pres-
ence of polybrene (4 ng/ml, H9268, Sigma-Aldrich). After 6–8 hr, cells were re-
plated on MEF cells or supportive human feeder cells expressing drug selec-
tion genes. Cells were either sorted based on GFP fluorescence or selected by
the hygromycin (10 mg/ml), puromycin (1 mg/ml), for 2 to 3 passages.
Transfection of hESCs
Lipofection and electroporation in hESCs were performed as described
previously (Cai et al., 2007).
g-Secretase Inhibitors and CBFRE Reporter Constructs
GSI-18 (synthesized by Dr. Yue-Ming Li), GSI-2 (cat. no. 565755, EMD Biosci-
ences) and DAPT (cat. no. D5942, Sigma-Aldrich) were used in the study.
CBFRE containing eight copies of wild-type or mutant CBF1 binding
sites (Hsieh et al., 1996) were cloned into pTA-Luc construct (Clontech
Laboratories).
Statistical Analysis
Data plotted are typically expressed as mean ± standard error of the mean
(SEM). Statistical analysis was performed using GraphPad Prism version 4.0
(GraphPad Software). Significance of differences was examined using the
Student’s t test (two-sided, unequal variance).
SUPPLEMENTAL DATA
The Supplemental Data include one table, seven figures, and Supplemental
Experimental Procedures and can be found with this article online at http://
www.cellstemcell.com/cgi/content/full/2/5/461/DC1/.470 Cell Stem Cell 2, 461–471, May 2008 ª2008 Elsevier Inc.ACKNOWLEDGMENTS
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